Loading viewer...
earnings
Format: PDF earnings
Alleima's Q2 2024 interim report shows revenues of SEK 5,359 million with adjusted EBIT margin of 11.1%, demonstrating resilience across diversified customer segments including Oil and Gas, Industrial, and emerging Medical and Nuclear sectors. The company reported strong free operating cash flow of SEK 486 million and maintained solid backlog despite cautious market conditions, with strategic initiatives in sustainable materials and clean energy applications driving long-term growth.
annual_report
178 Pages
earnings
29 Pages
Alma Media
ADM 2009 Shareholder Letter - Earnings & Strategy
earningsearnings
95 Pages
Archer Daniels Midland Company
Karyopharm Therapeutics Q2 2022 Financial Results & Business Update
earningsearnings
23 Pages
Karyopharm Therapeutics Inc.